|
|
Article: Bone metastases - can you teach an old drug new tricks? asks Datamonitor.
- Article from:
- Pharma Marketletter
- Article date:
- May 26, 2008
CopyrightCOPYRIGHT 2008 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced cancers become largely incurable once they have spread, or metastasized to the bone. Patients affected with bone metastases require supportive therapy in addition to anticancer treatment to manage skeletal complications. But while the bisphosphonates currently used to treat bone metastases reduce the risk of skeletal complications such as bone pain and fractures, they offer no survival benefit in the majority of patients. However, bisphosphonates may effectively prevent bone metastases in early-stage cancer patients, which could potentially revolutionize the management of this advanced complication, according to a new report by independent market analyst company ...